【科华生物(002022.SZ)获得“丙型肝炎病毒抗体诊断试剂盒”药品注册证书】智通财经APP讯，科华生物(002022.SZ)发布公告，近日，公司收到国家药品监督管理局颁发的《药品注册证书》。该产品为：“丙型肝炎病毒抗体诊断试剂盒(酶联免疫法)”，预期用途：用于体外定性检测人血清或血浆样本中的丙型肝炎病毒(HCV)抗体。

【科华生物(002022.SZ)获得“丙型肝炎病毒抗体诊断试剂盒”药品注册证书】智通财经APP讯，科华生物(002022.SZ)发布公告，近日，公司收到国家药品监督管理局颁发的《药品注册证书》。该产品为：“丙型肝炎病毒抗体诊断试剂盒(酶联免疫法)”，预期用途：用于体外定性检测人血清或血浆样本中的丙型肝炎病毒(HCV)抗体。

Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.